Skip to main content

Effect of glutathione-stabilized silver nanoparticles on expression of las I and las R of the genes in Pseudomonas aeruginosa strains



Biofilm formation is regarded as a significant factor in the establishment of infections caused by Pseudomonas aeruginosa. P. aeruginosa is one of the most important causes of nosocomial infections. Today silver nanoparticles (Ag-NPs) are used as antimicrobials due to their well-known, chemical, biological, and physical properties. Exposure to nanoparticles could inhibit colonization of new bacteria onto the biofilm.


In the present work, the green synthesis of Ag-NPs was performed using the alcoholic extract of Eucalyptus camaldulensis. Ag-NPs and glutathione-stabilized silver nanoparticles (GSH–Ag-NPs) were characterized using X-ray diffraction (XRD), dynamic light scattering (DLS), scanning electron microscope (SEM), and carbon, nitrogen, and hydrogen (CNH) and Fourier transform infrared spectroscopy (FTIR) techniques were applied to investigate the structure of the modified nanoparticles. Then, the antimicrobial and antibiofilm potential of the prepared Ag-NPs and GSH–Ag-NPs against P. aeruginosa strains was evaluated using microbroth dilution method and their effects on the expression of las I and las R genes.


In this study, a total of 50 P. aeruginosa isolates were recovered from clinical samples. According to the results, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) value of Ag-NPs against P. aeruginosa was determined to be 512–256 μg/ml, respectively, while the MIC and MBC value of GS–Ag-NPs against P. aeruginosa clinical strains was determined in a range of 128–256 μg/ml and 256–512 μg/ml, respectively. The mean expression level in las R, las I genes in P. aeruginosa strains treated with ½ MIC of Ag-NPs was decreased by −5.7 and −8fold, respectively. The mean expression levels of las R, las I genes in P. aeruginosa strains treated with ½ MIC of GS–Ag-NPs were decreased by −8.7 and −10fold, respectively (P < 0.05).


The results of our study showed that Ag-NPs and GS–Ag-NPs are highly effective against P. aeruginosa strains. Moreover, this study also proves the promising potential of using nanoparticles as anti-biofilm formation and antibacterial agents.


Pseudomonas aeruginosa is one of the most important causes of nosocomial infections especially in patients with cystic fibrosis, burns. Sepsis caused by P. aeruginosa is a serious complication in burn infections [1, 2]. In recent years, the widespread use of antibiotics has caused the emergence of P. aeruginosa strains that are resistant to broad-spectrum antibiotics from different classes. So far, the presence of multidrug-resistant (MDR) P. aeruginosa strains is a major problem in the treatment of infections caused by MDR in important hospital wards such as the burn unit and special care unit (ICU) [3]. Biofilms estimated to be related with 65% of nosocomial infections, and are considered as the major problem in medication because antibacterial agents such as disinfectants, heat, drying are not able to eliminate bacterial biofilms. Main reasons for the antibiotic resistance of biofilms are the limitation of antibiotic entry, reduced metabolism and slow growth, resistance genes. After biofilm exposure to antibiotics, resistant cell population leads to phenotypic adaptation [4,5,6]. Bacterial quorum sensing (QS) affects the overall process of biofilm development. The Lux IR-type QS systems are in P. aeruginosa. There are several virulence factors in P. aeruginosa regulated by two separate Lux systems including las and Rhl [7, 8]. P. aeruginosa uses its two major Las I/R and Rhl/I/R QS systems, the Las system regulating in a cascade the Rhl. These systems are responsible for synthesizing self-induced molecules called AI1 and AI2, respectively. These AIs are identified and interconnected by cytoplasmic transcription factors called Las R and Rhl R, respectively [8, 9]. Thus, in the search for novel antibacterial strategies, the use of nanoparticle agents has developed as a hopeful candidate. One of the applications of nanoparticles is their use as antimicrobial agents. Silver nanoparticles (Ag-NPs) are extensively used due to their small size. Ag-NPs have received much attention because of their anti-microbial and anti-inflammatory effects. Ag-NPs offer unique physicochemical characteristics such as good conductivity, chemical stability, catalytic activity and antibacterial and anti-inflammatory effects [10, 11]. The mechanism of the antibacterial effect of these NPs is due to the attachment to the surface of the cell membrane and disruption of permeability and respiratory functions of cells and inactivating membrane proteins. These NPs can also pass through the cell wall and/or the membranes of bacteria and bind to bacterial DNA and disrupt DNA replication. Furthermore, they can interfere in ribosomal function to translate mRNA into protein forms, and so they activate cytochrome B proteins [12].

Several methods have been used for green synthesis of Ag-NPs by using biological reducing material such as plant extracts and bacteria. Among these biological agents, plant extracts are desirable due to their low cost and accessibility. In the green methods, NPs are made up of plants, algae, etc. On the other hand, for increasing the absorption capacity of the drug on the surface of the NPs, they can be covered with various materials [10, 11]. Eucalyptus is one of the most famous herbs in the Myrtaceae family, and its antimicrobial activity has gained considerable attention since ancient times. This plant is rich in polyphenols and terpenoids, and the main components of its leaf include eucalyptol or cineol (70 to 80%). The members of this family are a major source of essential oils with broad biological activities, including anti-oxidant, anti-bacterial and antifungal properties [10, 13]. Glutathione (GSH) is a tripeptide (γ-Glu-Cys-Gly) which contains a –SH group. This peptide can be a reducing agent and coating agent, and can produce uniformly water-soluble nanoparticles to easily attach antibiotics. This characteristic has an important role in medical applications [14]. Thus, in the present study, for the first time, we evaluate antibacterial and antibiofilm potential of the Ag-NPs and Ag-NPs functionalized with GSH against P. aeruginosa strains using the phenotypic method and associate it with the expression level of the las R and las I genes.


Bacterial strains and culture conditions

A total of 50 P. aeruginosa strains were randomly collected from clinical samples, including wounds, blood, urine and sputum of patients admitted to a teaching hospital of Tehran University of Medical Sciences during the years 2017 and 2018. The isolated P. aeruginosa strains were confirmed using Gram-staining; catalase and oxidative–fermentative tests, growth on a MacConkey agar at 44 °C and oxidase and urease tests; Simon citrate and Kligler’s iron agar (KIA) and sulfide indole motility test [15]. Standard P. aeruginosa strains named PAO1 were applied as positive control.

Biofilm formation assays

The biofilm formation of the isolated P. aeruginosa strains were analyzed by using the microtiter plate assay [15]. In summary, the P. aeruginosa isolates were cultured in 5 ml of tryptic soy broth (TSB) medium containing 1% glucose and incubated at 37° C for 24 h. The cultures were diluted 1:100 in TSB medium. Sterile flat-bottomed 96-well polystyrene microtiter plates were inoculated with 125 µl bacterial suspension (final concentration 1 × 107 colony-forming unit (CFU)/μl) and incubated for 24 h at 37 °C. After incubation, the wells were washed in triplicate with 250 μl distilled water and then dried. Afterward, 200 μl of methanol was added to the wells for fixation. Next, 200 μl of 1% crystal violet solution was added to each well for about 10–15 min. After staining, each wall was washed three times with 250 μl of distilled water, and then dried with 125 µl of 30% acetic acid in water. The absorbance of the samples was read using an enzyme-linked immunosorbent assay (ELISA) at a wavelength of 570 nm. TSB culture medium without bacteria was used as a negative control. The interpretation of the testing results of biofilm production was carried out according to the following equation [15]:

$${\text{ODc}}{\mkern 1mu} = {\mkern 1mu} {\text{average OD of negative control}}{\mkern 1mu} + \left( {{\mkern 1mu} 3{\mkern 1mu} \times {\mkern 1mu} {\text{SD of negative control}}} \right),$$

where ODc is the optical density cut-off value.

Detection of las R and las I genes

DNA extraction from the P. aeruginosa isolates were performed using the Favorgen Biotech Corp (Taiwan) according to the protocol provided by the manufacturer. DNA was quantified by spectrophotometry (Thermo Scientific™ Nano Drop 2000c) over the wavelength range 260–280 nm. Polymerase chain reaction (PCR) was performed to identification the lasR and lasI genes and a reference gene (16s rRNA). The primers are presented in Table 1. The parameters for the amplification were 35 cycles of denaturation at 94 °C for 1 min, annealing at 60 °C for 1 min, and extension at 72 °C for 2 min. The P. aeruginosa strain PA01 was used as the positive control.

Table 1 Primers used in this study

Extract preparation

The leaves of eucalyptus plant were obtained from the Iranian Center for Genetic Reserves, which belongs to Eucalyptus camaldulensis species. In this study, alcoholic extract of Eucalyptus plant was used to prepare silver nanoparticles using green synthesis method. To prepare the alcoholic extract of the plant, the leaves of the eucalyptus plant were washed and dried. The dried leaves were then chopped and crashed into soft powder. Five grams of the eucalyptus was weighed, and diluted with 96% alcohol. Then, the mixture was placed on magnetic stirrer for 24 h. After this time, the extract was completely filtered with Whatman filter paper. Next, 100 ml of silver nitrate (5 M) was added to 140 ml of the extract. Then, the supernatant was removed, and the precipitated materials were stored at room temperature.

Chemical modification of surface structure of Ag-NPs

In order to modify the structure of the Ag-NPs with glutathione amino acids, 20 cc of L-glutathione (Sigma-Aldrich) solution was diluted with 0.01 g of Ag-NP. The obtained mixture was sonicated/vortexed for 30 min, and then placed in a dark place for 5 h. The flask was placed on a rotary shaker at 640 rpm. Finally, the mixtures were centrifuged at 4000 rpm for 5 min. The supernatant was removed and the precipitated materials were collected and stored in a dry place. Then, X-ray diffraction (XRD), dynamic light scattering (DLS), scanning electron microscope (SEM), and carbon, nitrogen, and hydrogen (CNH) and Fourier transform infrared spectroscopy (FTIR) techniques were applied to investigate the structure of the modified nanoparticles.

Determination of MIC and MBC of GS–Ag-NPs and Ag-NPs

MIC and MBC tests with GS–Ag-NPs and Ag-NPs were performed, using a standard broth microdilution method. In this step, 96-well microtiter plates were used for NPs. Aliquots of 100 μl of the Muller Hinton broth (MHB) was added into the wells of plate. Subsequently, in one of the plates, 100 μl of the serially diluted NPs were added in the first well. The bacterial suspension was then added to them 100 μl and the plates were incubated at 37 °C for 24 h.

Total RNA extraction, complementary DNA (cDNA) synthesis, and real-time PCR processing

Twelve P. aeruginosa strains with the strong biofilm formation ability as well as P. aeruginosa PAO1 were used for positive control molecular investigation. P. aeruginosa strains were grown in TSB at static condition in the presence of ½ MIC of GS–Ag-NPs and Ag-NPs. After incubation for overnight at 37 °C, bacterial cells were harvested using vortexing and then, centrifugation at 5000g for 10 min. Bacterial cells were subjected to RNA extraction using TRIzol™ RNA extraction kit (Thermo Fisher Scientific, USA) according to the manufacturer’s instructions. Then, synthesis of cDNA was carried out using according Vivantis™ cDNA synthesis kit (Malaysia).Expression of las I and las R genes were quantified using quantitative real-time PCR (qRT-PCR) assay. The qRT-PCR assay was performed in a 20-μl reaction mixture containing 10 μl Real QPlus 2 × Master Mix Green, High ROX (Ampliqon Co, Denmark), 2 μl cDNA, 0.5 μl of (10 pmol) each forward and reverse primers (Table 1), and 6 μl of DEPC-treated water, under the thermal cycling conditions: initial denaturation at 94 °C for 5 min, followed by 40 cycles of denaturation at 94 °C for 5 s, annealing at 60 °C for 20 s, and extension at 72 °C for 30 s. Then, a final extension at 72 °C for 5 min was conducted. Negative control (contained the reagents of the reaction, but lacked cDNA), and DNA sample were included in each run as a positive control. The expression levels of las I and las R genes were calculated relative to the calibration sample an internal control 16S rRNA to normalize the sample input. The changes in the expression level of target gene were analyzed by using the method adopted by Livak and Schmittgen [19].

Statistical analysis

Statistical analyses were performed using SPSS v21 (IBM Corp. New York, USA). The assays were performed in triplicates. The difference between the expression of target genes in the control and treated samples was calculated by T test. The data were reported as duplicate and melt curve with considering a significance level of 0.05.


Biofilm production

In the quantitative biofilm determination using the microtiter plate assay revealed that 49 isolates (98%) produced biofilm and the remaining 1 isolate did not, being distributed in the following categories: 48% (24/50) strong biofilm producer, 32% (16/50) moderate biofilm producer, and 18% (9/50) weak biofilm producer. All strains selected were based on strong-to-medium biofilm formation. Optical density values [17] of biofilm formation inhibition of the 12 isolates in the presence of ½ MIC concentration of Ag-NPs and GS–Ag-NPs are presented in Table 2.

Table 2 The profiles of biofilm formation in P. aeruginosa in ½ MIC concentration of GS–Ag-NPs and Ag-NPs (P < 0.05)

Detection of las I and las R genes

In this study, a high occurrence of biofilm-related genes was found, 100% and 98% of the isolates presented the las R and las I genes, respectively (Fig. 1).

Fig. 1
figure 1

Agarose gel electrophoresis of las I and las R genes among the P. aeruginosa strains PCR products. M; size of DNA marker (50-bp), lane 1; (negative control) (PCR product of qnr A and qnr B gene) and lane 2; (positive control of las I gene), lane 3; (PCR product of las I gene in clinical strains), lane 4; (positive control of las R gene), lane 5; (PCR product of las R gene in clinical strains)

Ultraviolet–visible spectroscopy analysis

An ultraviolet–visible spectroscopy was used to confirm the synthesis of Ag-NPs at wavelengths range of 350–800 nm. This analysis was performed 2 h before the addition of nitrate silver and 24 h after the addition of silver nitrate to the eucalyptus alcoholic extract. Figure 2 shows ultraviolet–visible absorption spectra of the eucalyptus alcoholic extract before and after adding silver nitrate. According to the results, the value of Lambda (λ) max was obtained at 450 nm.

Fig. 2
figure 2

a Absorption spectrum of eucalyptus extract before adding silver nitrate; b absorption spectrum of eucalyptus extract after adding silver nitrate

SEM analysis of Ag-NPs and GS–Ag-NPs

SEM image in Fig. 3 shows the morphological character of silver nanoparticles had a smooth surface. While the GS–Ag-NPs had a spherical structure. This SEM image also showed the aggregation of the silver nanoparticles.

Fig. 3
figure 3

SEM analysis of a silver nanoparticles; b glutathione-stabilized silver nanoparticles (GS–Ag-NPs)

DLS analysis of nanoparticles

DLS is able to probe the size distribution of small particles a scale ranging from submicron down to one nanometer in solution or suspension. The results obtained in size distribution from DLS analysis show the polydispersity index (PDI) was 0.440 with a Z-average of 747.4 nm.

XRD studies

The XRD pattern showed the main diffraction peaks of crystalline silver nanoparticles were appeared at 38.16º, 46.26º, 64.52º, 76.78º, which correspond to 111, 200, 220 and 311 planes, respectively, which are closely consistent with the standard peaks of silver nanocrystals. The XRD pattern shows that the silver nanoparticles were structurally modified with the l-glutathione amino acid. According to the results, after modification of the nanoparticles, the peak positions of the silver crystalline surface are still present and slightly shifted toward higher values, which confirmed the presence of the silver nanoparticle core modified with glutathione (Fig. 4).

Fig. 4
figure 4

Measurement of size distribution of nanoparticles

FTIR analysis Ag-NPs, GSH and GS–Ag-NPs

The peak at 720 cm−1 in Fig. 5a and 624 cm−1 in Fig. 5b confirmed the presence of metal nanoparticles. The peaks observed at 1172, 1383, 1618 and 1458 cm−1 correspond to the functional groups of C–O, COO, NH, CH2, respectively. Also, the peak observed in 3413 cm−1 is related to OH, which may be attributed to plant extract residues. In the glutathione spectrum, the absorption peak at 1384 cm−1 is attributed to the COO functional group in the amino acid composition, and the peak at 1616 cm−1 is due to NH functional group and peak at 3556 cm−1 is due to OH-group. The adsorption peak at 2533 cm−1 is related to the SH group in the glutathione tripeptide (γ-Glu-Cys-Gly). In the spectrum of the modified nanoparticles, the disappearance of this peak indicated the involvement of various functional groups in bonding of the nanoparticles (Fig. 5c).

Fig. 5
figure 5

FTIR spectra of a Silver nanoparticles; b glutathione and c GS–Ag-NPs

CNH analysis of Ag-NPs and GS–Ag-NPs

According to the CNH analysis, the percentages of carbon, hydrogen and nitrogen were 56.55%, 7.48%, and 17.1%, respectively. The carbon content of this group was related to nanoparticles. Based on the results, the carbon content of the silver-modified nanoparticles modified with L-glutathione amino acid was greater than 27.37%, hydrogen content was 88.11% and nitrogen content was 0%. The presence of carbon and hydrogen in the sample confirmed the binding of glutathione tripeptide to the surface of the silver nanoparticles, because these nanoparticles do not have such groups.

MIC and MBC of Ag-NPs and GS–Ag-NPs against P. aeruginosa strains

According to the results, The MIC and MBC value of Ag-NPs against P. aeruginosa was determined 256 and 512 μg/ml, respectively. While the MIC and MBC value of GS–Ag-NPs against P. aeruginosa clinical strains was determined in a range of 128 and 256 μg/m, respectively (Table 3).

Table 3 Determination of MIC and MBC of Ag-NPs and GS–Ag-NPs agents against P. aeruginosa strains

Effect of ½ MIC of GS–Ag-NPs on the expression of genes associated with biofilm production (las I, las R)

After treatment of the isolates with ½ MIC of Ag-NPs modified with l-glutathione, the RNA was first extracted, and then the cDNA was synthesized. Next, the quantitative expression of the gene-associated biofilm (Las I, Las R) and the 16S rRNA reference gene were measured using the real-time PCR. After treatment of P. aeruginosa strains with ½ MIC of the modified silver nanoparticles, they were treated with L-glutathione as well. A significant decrease was observed in the gene expression of Las R and Las I compared with the untreated groups (P < 0.05). The mean expression level in Las R, Las I genes in P. aeruginosa strains treated with ½ MIC of Ag-NPs were decreased by 5.7 and eightfold, respectively (P < 0.05).The mean expression level in Las R, Las I genes in P. aeruginosa strains treated with ½ MIC of GS–Ag-NPs were decreased by 8.7- and 10-fold, respectively (P < 0.05).


Bacterial biofilm formation in healthcare is a significant problem in medicine. Biofilm formation by bacteria causes higher resistance to antimicrobials due to the decrease of antimicrobial penetration and easier exchange of resistance genes between bacteria. Therefore, biofilm formation is regarded as an essential pathogenicity determinant and the resulting infections are challenging to treat [20]. The world spread of antibiotic resistance has increased the need to develop new antimicrobial agents. Ag-NPs have gained much attention as a suitable option for eradicating biofilms and antimicrobial agents [21]. The key cause of antibacterial behavior of such NPs could be attributed for the charge transfer mechanisms taking place between bacteria and the NPs. For the reason that of these characteristics such as, coating/capping, particle composition, dissolution rate, efficiency of ion release, size distribution, particle reactivity in solution, size, shape, particle morphology and agglomeration, Ag-NPs have been used widely in the health care industry, and in food storage, biomedical, and environmental applications. We accomplished a first antimicrobial assessment of synthesized Ag-NPs and glutathione-stabilized silver nanoparticles (GSH–Ag-NPs) by determination of MIC and MBC against P. aeruginosa strains. The obtained results prove a significant antibacterial activity of Ag-NPs and GS–Ag-NPs with bactericidal effects at the concentration of means 1024 and 256 µg/ml against P. aeruginosa strains, respectively (Table 2). This demonstrates the findings obtained by other researchers, which showed Ag is a potent antibiotic against a wide range of bacteria at a very low concentration without having any damaging effect on body tissues [22, 23]. Sondi et al. showed microorganisms treated with Ag-NPs exhibited the accumulation of Ag-NPs in the cell wall and the formation of “pits” in the bacterial cell walls, ultimately leading to cell death [24]. Kim et al. investigated the efficiency of the antimicrobial effects of Ag-NPs against yeast, Staphylococcus aureus and E. coli. The results show that at low concentrations of Ag-NPs, the inhibition of growth was observed in yeast, E. coli and S. aureus [25]. Silvan et al. evaluated the antimicrobial effectiveness of GSH–Ag-NPs against multidrug resistant (MDR) Campylobacter strains. The results obtained showed that GSH–Ag-NPs were highly effective against Campylobacter strains tested; the findings of this study confirm our results [26]. Thus, a covering of glutathione (GSH) increases the solubility and the capability of AgNPs to interact with the environment [23]. Also, the antimicrobial effect of Ag-NPs is due to release of Ag+ ions from Ag-NPs, which make an additional involvement to the bactericidal effect. Indeed, Ag-NPs where Ag+ is present in the Ag0 form also contain small concentrations of Ag+, and both Ag+ and Ag0 contribute to the antibacterial activity [26]. Researchers claim the antibacterial activity of the NPs may be due to the active permeability of bacterial cells through the cell wall layers or its charges. The antibacterial activity studies have demonstrated that NPs may enter the cell and attachment to cell receptors causing intracellular disintegration leading to cell death and inhibition of essential metabolic enzymes resulting in disruption of bacterial cell reproduction and respiration. Ag-NPs antibacterial mechanism works by inhibiting O2 metabolism, which finally kills the microbes in a very short time [27]. Moreover, it has been reported that Ag-NPs could efficiently reduction bacterial biofilm biomass [20]. These findings indicate that the antibiofilm activity of 512 μg/ml of Ag-NPs and 256 μg/ml GSH–Ag-NPs could slightly degradation bacterial biofilm (Table 3). These findings are very similar to Mohanty et al.’s report that tested anti-biofilm activities of varying concentrations of Ag-NPs against P. aeruginosa that reported a reduction in biofilm formation by P. aeruginosa [28]. The antibiofilm activity of Ag-NPs has been demonstrated in a number of studies such as Sondi et al., Montazeri et al., Besinis et al., Gurunathan et al., Kalishwaralal et al., have demonstrated the potential anti-biofilm activity Ag-NPs against Gram-negative and Gram-positive bacterial [20, 29,30,31]. Franci et al. demonstrated that Ag-NPs exhibit effective biofilm inhibition of against Pseudomonas putida biofilms [32]. Ramasamy et al. exhibited that antibiofilm Ag-NPs decrease the biofilm formation by P. aeruginosa [33], Shafreen et al. reported for Ag-NPs an MIC of 300 ng/ml against a biofilm formed by E. coli [34].

Here, Ag-NPs not only inhibited the growth, but also the capability of the bacterium to synthesize the exopolysaccharide. This shows that Ag-NPs have the ability to block the exopolysaccharide synthesis of the bacterium then the biofilm. This inhibitory and degradation effect of Ag-NPs on the biofilm formation may due to be existence of water channels (pores) throughout the biofilm. The water channels are present for nutrient transportation; Ag-NPs may directly diffuse through the exopolysaccharide layer through the pores and may impart antibacterial actions [35].

In this study, we showed that exposure of P. aeruginosa strains to ½ MIC concentration of GSH–Ag-NPs significantly reduced expression of both las I and las R genes reduced compared to the control sample, which could be regarded as the main cause of biofilm inhibition between P. aeruginosa strains (P < 0.05). Our results showed that GSH–Ag-NPs not only reduced biofilm formation ability of P. aeruginosa strains, but also reduced the expression of the main genes associated with biofilm formation. Hentzer et al. wherein HFs have shown antiquorum-sensing activity in P. aeruginosa by inhibiting the expression of fabH2 gene, our results are consistent with this the report [36]. Nejabatdoust et al. showed that functionalization of ZnO NPs with Tsc could significantly increase efficiently reduced expression of the major efflux pump genes in MDRS. aureus strains [37]. Consequently, penetration of Ag-NPs into the bacterial cells could interrupt several cellular functions including gene expression. In other words, the NPs inhibit cytoplasmic proteins via direct attachment which describe the reduced expression of biofilm-associated genes. Montazeri et al. reported that at sub-inhibitory concentration of Ag-NPs conjugated to thiosemicarbazide reduced expression of ica A and ica D genes the biofilm formation related between methicillin resistance S. aureus, the results from this study support the finding [20]. In another study, Gheidar et al., showed that exposure to Ag-NPs reduced the expression of fnbA and fnbB genes [38]. In addition to the all the mentioned mechanisms of biofilm inhibition in P. aeruginosa, internalization of the NPs into the bacterial cells and inhibition of cellular components may affect expression of a different set of biofilm association genes, which need further research.


Ag-NPs can be utilized for beneficial biological application. Glutathione functionalization of noble metal Ag-NPs may improve their biological activity. The Ag-NPs thus prepared tend to aggregate together upon addition of Ag+ due to the strong coordination bond between Ag+ and –NH2, –COOH of glutathione modifier. The findings of this study indicated that the glutathione-modified silver nanoparticles at a concentration of ½ MIC reduced the expression of las I and las R genes associated with biofilm production in P. aeruginosa. Nevertheless, further studies must be conducted to assess the toxicity of the NPs in in vitro and in vivo conditions.

Availability of supporting data

Not applicable.



Silver nanoparticles


X-ray diffraction


Dynamic light scattering


Scanning electron microscope


Carbon, nitrogen, and hydrogen


Fourier transform infrared spectroscopy


Glutathione-stabilized silver nanoparticles


Multidrug resistant


Special care unit


Quorum sensing






Kligler’s iron agar


Sulfide indole motility


Tryptic soy broth


Colony forming count


Enzyme-linked immunosorbent assay


Optical density cut-off


Polymerase chain reaction


Minimum inhibitory concentration


Muller Hinton broth


Complementary DNA


Reactive oxygen species


  1. Oluyombo O, Penfold CN, Diggle SP. Competition in biofilms between cystic fibrosis isolates of Pseudomonas aeruginosa is shaped by R-pyocins. mBio. 2019;10(1):e01828.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cornut P-L, Thuret G, Creuzot-Garcher C, Maurin M, Pechinot A, Bron A, et al. Relationship between baseline clinical data and microbiologic spectrum in 100 patients with acute postcataract endophthalmitis. Retina. 2012;32(3):549–57.

    Article  PubMed  Google Scholar 

  3. Tsukayama D, Van Loon H, Cartwright C, Chmielewski B, Fluit A, Van der Werken C, et al. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial. Int J Antimicrob Agents. 2004;24(4):339–45.

    Article  CAS  PubMed  Google Scholar 

  4. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322–32.

    Article  PubMed  CAS  Google Scholar 

  5. Ghotaslou R, SalahiEshlaqghi B. Biofilm of pseudomonas aeruginosa and new preventive measures and anti-biofilm agents. J Rafsanjan Univ Med Sci. 2013;12(9):747–68.

    Google Scholar 

  6. McLean RJ, Lam JS, Graham LL. Training the biofilm generation—a tribute to JW Costerton. J Bacteriol. 2012;194(24):6706–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Köhler T, Guanella R, Carlet J, Van Delden C. Quorum sensing-dependent virulence during Pseudomonas aeruginosa colonisation and pneumonia in mechanically ventilated patients. Thorax. 2010;65(8):703–10.

    Article  PubMed  Google Scholar 

  8. Lee K, Yoon SS. Pseudomonas aeruginosa biofilm, a programmed bacterial life for fitness. 2017.

    Article  CAS  PubMed  Google Scholar 

  9. Paczkowski JE, Mukherjee S, McCready AR, Cong J-P, Aquino CJ, Kim H, et al. Flavonoids suppress Pseudomonas aeruginosa virulence through allosteric inhibition of quorum-sensing receptors. J Biol Chem. 2017;292(10):4064–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Panigrahi T. Synthesis and characterization of silver nanoparticles using leaf extract of Azadirachta indica 2013.

  11. Kaler A, Patel N, Banerjee UC. Green synthesis of silver nanoparticles. Curr Res Inf Pharm Sci. 2010;11(4):68–71.

    Google Scholar 

  12. Kwakye-Awuah B, Williams C, Kenward M, Radecka I. Antimicrobial action and efficiency of silver-loaded zeolite X. J Appl Microbiol. 2008;104(5):1516–24.

    Article  CAS  PubMed  Google Scholar 

  13. Asha S, Thirunavukkarasu P, Rajeshkumar S. Eco-friendly synthesis of silver nanoparticles using aqueous leaves extract of cleome gynandra and their antibacterial activity. Int J Pharmaceut Res. 2017;9:32–7.

    Google Scholar 

  14. Amirghofran Z. Medicinal plants as immunosuppressive agents in traditional Iranian medicine. Iran J Immunol. 2010;7(2):65–73.

    CAS  PubMed  Google Scholar 

  15. Mahmoudi H, Pourhajibagher M, Chiniforush N, Soltanian AR, Alikhani MY, Bahador A. Biofilm formation and antibiotic resistance in methicillin-resistant and methicillin-sensitive Staphylococcus aureus isolated from burns. J Wound Care. 2019;28(2):66–73.

    Article  PubMed  Google Scholar 

  16. Sabharwal N, Dhall S, Chhibber S, Harjai K. Molecular detection of virulence genes as markers in Pseudomonas aeruginosa isolated from urinary tract infections. Int J Mol Epidemiol Genet. 2014;5(3):125.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Lima JLC, Alves LR, Jacomé PRLA, Neto B, Pacífico J, Maciel MAV, et al. Biofilm production by clinical isolates of Pseudomonas aeruginosa and structural changes in LasR protein of isolates non biofilm-producing. Braz J Infect Dis. 2018;22(2):129–36.

    Article  PubMed  Google Scholar 

  18. Ahmadi K, Hashemian AM, Bolvardi E, Hosseini PK. Vancomycin-resistant Pseudomonas aeruginosa in the cases of trauma. Med Arch. 2016;70(1):57.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–8.

    Article  CAS  PubMed  Google Scholar 

  20. Montazeri A, Salehzadeh A, Zamani H. Effect of silver nanoparticles conjugated to thiosemicarbazide on biofilm formation and expression of intercellular adhesion molecule genes, icaAD, in Staphylococcus aureus. Folia Microbiologica. 2019;1:1–8.

    Google Scholar 

  21. Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res. 2002;66(2):86.

    PubMed  PubMed Central  Google Scholar 

  22. Caufield PW, Dasanayake AP, Li Y, Pan Y, Hsu J, Hardin JM. Natural history of Streptococcus sanguinis in the oral cavity of infants: evidence for a discrete window of infectivity. Infect Immun. 2000;68(7):4018–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Singh M, Singh S, Prasad S, Gambhir I. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Digest J Nanomater Biostruct. 2008;3(3):115–22.

    Google Scholar 

  24. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E coli as a model for Gram-negative bacteria. J Coll Interface Sci. 2004;275(1):177–82.

    Article  CAS  Google Scholar 

  25. Kim JS, Kuk E, Yu KN, Kim J-H, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3(1):95–101.

    Article  CAS  PubMed  Google Scholar 

  26. Murariu M, Stoica I, Gradinaru R, Drochioiu G, Mangalagiu I. Glutathione-based silver nanoparticles with dual biomedical activity. Rev Roum Chim. 2014;59(10):867–74.

    Google Scholar 

  27. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 2007;3(2):168–71.

    Article  CAS  PubMed  Google Scholar 

  28. Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine. 2012;8(6):916–24.

    Article  CAS  PubMed  Google Scholar 

  29. Besinis A, De Peralta T, Handy RD. The antibacterial effects of silver, titanium dioxide and silica dioxide nanoparticles compared to the dental disinfectant chlorhexidine on Streptococcus mutans using a suite of bioassays. Nanotoxicology. 2014;8(1):1–16.

    Article  CAS  PubMed  Google Scholar 

  30. Gurunathan S, Han JW, Eppakayala V, Jeyaraj M, Kim J-H. Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. BioMed Res Int. 2013;2013:535796.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Kalishwaralal K, Deepak V, Ramkumarpandian S, Nellaiah H, Sangiliyandi G. Extracellular biosynthesis of silver nanoparticles by the culture supernatant of Bacillus licheniformis. Mater Lett. 2008;62(29):4411–3.

    Article  CAS  Google Scholar 

  32. Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, et al. Silver nanoparticles as potential antibacterial agents. Molecules. 2015;20(5):8856–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ramasamy M, Lee J-H, Lee J. Direct one-pot synthesis of cinnamaldehyde immobilized on gold nanoparticles and their antibiofilm properties. Colloids Surf B. 2017;160:639–48.

    Article  CAS  Google Scholar 

  34. Rajkumari J, Meena H, Gangatharan M, Busi S. Green synthesis of anisotropic gold nanoparticles using hordenine and their antibiofilm efficacy against Pseudomonas aeruginosa. IET Nanobiotechnol. 2017;11(8):987–94.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B. 2010;79(2):340–4.

    Article  CAS  Google Scholar 

  36. Hentzer M, Riedel K, Rasmussen TB, Heydorn A, Andersen JB, Parsek MR, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology. 2002;148(1):87–102.

    Article  CAS  PubMed  Google Scholar 

  37. Nejabatdoust A, Zamani H, Salehzadeh A. Functionalization of ZnO nanoparticles by glutamic acid and conjugation with thiosemicarbazide alters expression of efflux pump genes in multiple drug-resistant Staphylococcus aureus strains. Microbial Drug Resist. 2019;25(7):966–74.

    Article  CAS  Google Scholar 

  38. Gheidar H, Haddadi A, Kalani BS, Amirmozafari N. Nanoparticles impact the expression of the genes involved in biofilm formation in S. aureus, a model antimicrobial-resistant species. J Med Bacteriol. 2018;7(34):30–41.

    CAS  Google Scholar 

Download references


Not applicable.


Not applicable.

Author information

Authors and Affiliations



MPM and HM designed the study. MPM and HM performed the experiments. MPM and HM performed the data analysis. HM drafted the manuscript. HM supervised the project. All authors contributed to the interpretation of the results, provided critical feedback, contributed to the writing of the manuscript. Both authors read and approved the final manuscript.

Corresponding author

Correspondence to Hassan Mahmoudi.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pourmbarak Mahnaie, M., Mahmoudi, H. Effect of glutathione-stabilized silver nanoparticles on expression of las I and las R of the genes in Pseudomonas aeruginosa strains. Eur J Med Res 25, 17 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: